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a  b  s  t  r  a  c  t
Oxytocin  is a peptide  drug  used  to induce  labor  and  prevent  bleeding  after  childbirth.  Due to its  instabil-
ity,  transport  and  storage  of oxytocin  formulations  under  tropical  conditions  is  problematic.  In  a previous
study,  we  have  found  that the  stability  of oxytocin  in aspartate  buffered  formulation  is  improved  by the
addition  of divalent  metal  ions  (unpublished  results).  The  stabilizing  effect  of  Zn2+ was  by far  superior
compared  to  that  of Mg2+. In addition,  it was  found  that  stabilization  correlated  well  with  the  ability  of
the  divalent  metal  ions  to interact  with  oxytocin  in  aspartate  buffer.  Furthermore,  LC–MS  (MS) measure-
ments  indicated  that the  combination  of  aspartate  buffer  and  Zn2+ in particular  suppressed  intermolecular
degradation  reactions  near  the Cys1,6 disulﬁde  bridge.  These  results  lead  to  the hypothesis  that  in  aspar-
tate  buffer,  Zn2+ changes  the  conformation  of  oxytocin  in such  a way  that  the Cys1,6 disulﬁde  bridge
is  shielded  from  its  environment  thereby  suppressing  intermolecular  reactions  involving  this  region
of  the  molecule.  To  verify  this  hypothesis,  we  investigate  here  the  conformation  of  oxytocin  in aspar-
tate  buffer  in  the  presence  of  Mg2+ or Zn2+, using  2D  NOESY,  TOCSY, 1H–13C HSQC  and 1H–15N  HSQC
NMR spectroscopy.  Almost  all 1H, 13C and 15N  resonances  of oxytocin  could  be  assigned  using  HSQC
spectroscopy,  without  the need  for 13C or 15N enrichment. 1H–13C  and 1H–15N HSQC  spectra  showed
that aspartate  buffer  alone  induces  minor  changes  in  oxytocin  in  D2O,  with  the  largest  chemical  shift
changes  observed  for  Cys1. Zn2+ causes  more  extensive  changes  in  oxytocin  in  aqueous  solution  than
Mg2+.  Our  ﬁndings  suggest  that  the carboxylate  group  of aspartate  neutralizes  the  positive  charge  of the
N-terminus  of  Cys1, allowing  the  interactions  with  Zn2+ to  become  more  favorable.  These  interactions  may
explain  the  protection  of the  disulﬁde  bridge  against  intermolecular  reactions  that  lead  to  dimerization.. Introduction
Oxytocin is a nonapeptide hormone secreted by the pos-
erior lobe of the pituitary gland, and is involved in the
ontrol of labor and bleeding cessation after child birth
Maughan et al., 2006). The peptide consists of nine amino acids
Cys–Tyr–Ile–Gln–Asn–Cys–Pro–Leu–Gly–NH2) with an internal
isulﬁde bridge, and an amidated C-terminus (du Vigneaud et al.,
953). Oxytocin is the preferred drug to prevent postpartum hem-
rrhage and is commonly formulated in aqueous solution for
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parenteral administration (Gard et al., 2002). The instability of
oxytocin in aqueous solution under harsh circumstances, partic-
ularly under tropical conditions, presents a signiﬁcant challenge
to pharmaceutical scientists (Hawe et al., 2009). The instability of
oxytocin in aqueous solution has been reported in several stud-
ies (Hogerzeil et al., 1993; Trissel et al., 2006). It has been found
that the degradation rate strongly depends on the pH of the formu-
lation, with the highest stability reported at pH 4.5 (Hawe et al.,
2009). Several studies have been aimed at the improvement of
the stability of oxytocin in aqueous solution (Avanti et al., 2011;
Hawe et al., 2009). The most recent ﬁnding is that the use of
divalent metal ions, in combination with certain buffers, strongly
increases the stability of oxytocin in aqueous solution (Avanti et al.,
2012).
Previously, we  have shown that Zn2+ in combination with
aspartate buffer strongly stabilizes oxytocin in aqueous solutions,
whereas Ca2+ and Mg2+ only have minor effects. The stabilization
